Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3
Kentaro Tanaka(Institute for the Future), Chen Dong(East China University of Technology), Byung Seok Kim(The University of Texas MD Anderson Cancer Center), Lan Liao(Foshan University), Akihiko Yoshimura(Keio University), Yeonseok Chung(Seoul National University), Kenji Ichiyama(The University of Osaka), Jianming Xu(Baylor College of Medicine), Xiaowei Yan(Institute for Systems Biology), Pan Zheng(South China University of Technology), Bert W. O’Malley(Baylor College of Medicine), Weiwen Long(Wright State University), Joseph M. Reynolds(Rosalind Franklin University of Medicine and Science), Xinxin Chi(Harvard University), Xiaohu Wang(Institute of Modern Physics), Qiang Tian(Institute for Systems Biology), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences), Shinya Tanaka(The University of Osaka), Gustavo Martínez(The University of Texas MD Anderson Cancer Center)
Cited by 40
Related Papers
Regulatory T Cells and Human Disease
|Annual Review of Immunology|2020|1.1k
BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β-catenin signaling
|Nature Genetics|2004|1.1k
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
|Endocrine Reviews|2004|924
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
|The EMBO Journal|1995|758
1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
|Molecular and Cellular Biology|2011|456